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INTRODUCTION
Approximately one in 1,000 children is affected by severe or
profound hearing loss at birth or during early childhood, which
is defined as pre-lingual deafness (1). About one half of child-
hood hearing loss is thought to have a genetic etiology, the majori-
ty of which is non-syndromic and not associated with abnormal-
ities of other organ systems. Estimates from clinical and epidemi-
ological studies suggest that 80-85% of hereditary, non-syndro-
mic, pre-lingual deafness is autosomal recessive (1, 2). 
Pendred syndrome phenotypes are associated with enlarge-
ment of the vestibular aqueduct (EVA) as detected by radio-
logical imaging of the temporal bones (3).
We present a case of profound sensorineural hearing loss dur-
ing early childhood with homozygous H723R mutation for SLC-
26A4 associated with bilateral EVAs. 
CASE REPORT
The proband, a 3-yr-old boy, visited our clinic because of poor
response to sound after head injury two months ago. After the
accident, he became mute and timid, especially at his mother’s
absence. However, his mother reported he had been able to speak
two-word combination and telegraphic sentences before head
injury.
Otologic examination revealed normal-appearing and mobile
tympanic membranes. No palpable goiter was present. And other
findings of physical examination were unremarkable.
A sedated auditory brainstem response (ABR) revealed no
identifiable wave V peak at 90 dB in both ears. And distortion-
product otoacoustic emission (DPOAE) were absent in both ears.
To obtain frequency-specific information and to check any resid-
ual hearing for fitting hearing aid, auditory steady state response
(ASSR) was performed. ASSR showed significant response at
high signal intensity (Fig. 1). 
Temporal bone computed tomography showed bilateral EVA
with no anomaly in the middle and inner ear (Fig. 2).
We recommended bilateral fitting of hearing aids and audito-
ry rehabilitation prior to the decision to have cochlear implana-
tion. Even though he was improved in the detection of sound
and language with hearing aid, his performance was not satis-
factory to follow the normal course of language development.
After 6 months rehabilitation with hearing aids, cochlear implan-
tation was done on his left side. Preoperatively, repeated ABR
revealed no identifiable wave at 90 dB in the both ears. After
24 months of rehabilitation with bimodal binaural stimulation
with CI and hearing aid, the hearing threshold in the free field
was 27 dB A and the percentage of open-set monosyllabic word
recognition was 92% in audio-visual (AV) condition and 64%
in auditory only (AO) condition at 55 dB A.
Recessive mutations of the SLC26A4 (PDS) gene on chromosome 7q31 can cause sensorineural deafness with goiter
(Pendred syndrome, OMIM 274600) or NSRD with goiter (at the DFNB4 locus, OMIM 600791). H723R (2168A>G) is
the most commonly reported SLC26A4 mutations in Korean and Japanese and known as founder mutation. We recent-
ly experienced one patient with enlarged vestibular aqueduct syndrome. The genetic study showed H723R homozygous
in the proband and H723R heterozygous mutation in his family members. The identification of a disease-causing muta-
tion can be used to establish a genotypic diagnosis and provide important information to both families and their physi-
cians. 
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The genetic study showed H723R heterozygous mutation for
all other family members, except the proband who showed H723R
homozygous (Fig. 3). Thyroid function tests were performed to
evaluate any possible thyroid dysfunction related with SLC26A4
mutation. The thyroid function tests showed thyroid-stimulat-
ing hormone (TSH) of 1.11 mU/L (normal range, 0.93 to 1.7),
free triiodothyronine (FT3) of 4.0 pg/mL (normal range, 1.4 to
4.4), free thyroxine (FT4) of 1.84 ng/dL (normal range, 0.27 to
4.2), and thyroglobulin antigen of 33.6 ng/mL (normal range, 0
to 70). 
Genetic analysis
Mutations were detected by a combination of intronic polymerase
chain reaction (PCR) amplification, using primers flanking each
exon, and sequencing of the amplification products. Exons 1-21
of the SLC26A4 gene were amplified from a genomic DNA sam-
ples by PCR. Amplification was carried out in a Perkin-Elmer
thermal cycler using the following conditions: 5-min denatura-
tion at 95℃, 37 three-step cycles (95℃ for 30 sec, 55℃ for 1 min,
72℃ for 1 or 3 min), 72℃ for 10 min, and ending with a hold-
ing period at 4℃. The PCR products were directly sequenced
after removal of unincorporated dNTPs and primers by incuba-
tion of 50-100 ng PCR product at 37℃ for 30 min with 0.1 μ L
exonuclease I (Amersham Life Science, Cleveland, USA) and
1 μ L shrimp alkaline phosphatase (American Life Science). The
enzymes were heat-inactivated at 80℃ for 15 min. An aliquot
of 6 pmol of either the forward or the reverse primer was used
in standard cycle sequencing reactions with ABI Big Dye termi-
nators, and run on an ABI 377 sequencer.
Fig. 1. Auditory Steady State Response in the proband showing the estimated hearing threshold.
Fig. 2. An axial non-enhanced temporal bone CT revealing the widen
vestibular aqueduct (arrows).
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Fig. 3. (A) Pedigree of family
with the H723R mutation. Filled
wymbol indicates affected per-
son. The proband is marked
with an arrow. (B) Direct sequ-
encing chromatographs of the
H723R mutation. Father, moth-
er, and sister panel show the
heterozygote of the H723R mu-
tation. The proband panel sho-
ws the homozygote of the H-
723R mutation. Missense muta-
tion at nucleotide 2168 in exon
19 substituted arginine for his-
tidine at aminoacid 723. 102 Clinical and Experimental Otorhinolaryngology  Vol. 2, No. 2: 100-102, June 2009
DISCUSSION
Overall, SLC26A4 mutations may account for between 5 and
10% of patients with prelingual hearing loss (4). The gene is locat-
ed on chromosome 7q22-q31 and encodes a chloride-iodide
transporter that is expressed in the thyroid, inner ear, and kid-
ney. The gene has 21 exons that encode a 780 amino acid pro-
tein called pendrin, a 86 kDa glycoprotein with 11 or 12 trans-
membrane domains (5). 
Each ethnic population has its own distinctive, diverse series
of SLC26A4 mutant alleles which includes one or a few preva-
lent founder alleles (6). In Caucasoid populations, the mutations
IVS8+1G>A, L236P, and T416P account for nearly half of all
SLC26A4 mutation alleles (7). On the other hand, H723R, IVS7-
2A>G, and IVS9+3A> Gare common alleles and account for
the majority of SLC26A4 mutations in East Asian populations
(6). Especially, the mutation H723R accounts for 40% of SLC-
26A4 mutation in Korean (8) and 53% in Japanese patients (9)
and is the most frequently detected mutation in both Korean and
Japanese populations, as a result of a common founder effect (6).
The frequency of H723R heterozygote detection among normal
Korean control is reported as 1.6% (6).
The Pendred syndrome is characterized by congenital sensori-
neural hearing loss and goiter (10). However, the infrequent
detection of goiter may reflect reduced diagnostic sensitivity of
manual palpation, or the young ages of the probands, consider-
ing the tendency for goiter in Pendred syndrome to begin around
the time of puberty. Phenotypic variability has also been report-
ed in two families carrying the same PDS missense mutation (11).
Recent study reported that some missens pendrin product, hypo-
functional SLC26A4 alleles, affected transport activity of pen-
drin (12). A modifier gene, hypo-functional SLC26A4 variants,
or environmental factor (iodine uptake, nutrition, etc.) may con-
tribute to such variability (9, 11, 12). 
We successfully performed a cochlear implant on a patient
with EVA. In the absence of syndromic features to guide genet-
ic diagnosis, a detailed knowledge of the distribution of mutant
alleles at specific loci for individual populations is required for
more efficient diagnosis.
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